Protection from ischemia-reperfusion damage in patients with stroke: the role of rutin and GSH.
D000111:Acetylcysteine / Q000008:administration & dosage / Q000627:therapeutic use; D000368:Aged; D000704:Analysis of Variance; D000990:Antithrombin III / Q000032:analysis; D002449:Cell Aggregation; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D003566:Cytidine Diphosphate Choline / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005344:Fibrinopeptide A / Q000032:analysis; D005978:Glutathione / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D007962:Leukocytes / Q000502:physiology; D008297:Male; D008875:Middle Aged; D018697:Nootropic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015427:Reperfusion Injury / Q000517:prevention & control*; D012431:Rutin / Q000008:administration & dosage / Q000627:therapeutic use*; D013923:Thromboembolism / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology
D018697:Nootropic Agents; D005344:Fibrinopeptide A; D003566:Cytidine Diphosphate Choline; D012431:Rutin; D000990:Antithrombin III; D005340:Fibrinogen; D005978:Glutathione; D000111:Acetylcysteine